This randomized phase II study compared two treatment schedules of gemcitabine in patients with non–small-cell lung cancer (NSCLC) and impaired Karnofsky performance status (KP). Primary objectives ...
Please provide your email address to receive an email when new articles are posted on . The Karnofsky performance status independently predicted graft and patient survival before and after liver ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results